The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 12, 2025
Filed:
Feb. 21, 2024
Applicant:
Twelve Therapeutics, Inc., New York, NY (US);
Inventors:
Louis Grenier, Newton, MA (US);
Andre Lescarbeau, Somerville, MA (US);
Praveen Sharma, Arlington, MA (US);
Daniel G. Genov, Boston, MA (US);
Assignee:
Twelve Therapeutics, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 9/48 (2006.01); A61K 31/519 (2006.01); C07D 231/12 (2006.01); C07D 231/38 (2006.01); C07D 401/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/519 (2013.01); C07D 231/12 (2013.01); C07D 231/38 (2013.01); C07D 401/06 (2013.01); C07B 2200/13 (2013.01);
Abstract
Solid forms of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphic forms, cocrystals, and amorphous forms thereof, and pharmaceutical compositions thereof.